Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyronaridine-Artesunate vs Artemether-Lumefantrine in Children with Acute Uncomplicated Malaria
NCT05192265Phase 3Completed
- Start
- May 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pyronaridine in Plasmodium falciparum malaria. Started May 2019; status: completed.
02
Drugs
pyronaridine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT05192265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05192265.